Filing Flows › BioAge Labs (BIOA) › Q3 2026 › vs Q3 2025
BioAge Labs (BIOA) Q3 2026 vs Q3 2025 (year over year)
BioAge Labs's revenue fell $1.8M (-85%) from $2.1M in Q3 2025 to $298K in Q3 2026.
BioAge Labs, Q3 2026: revenue $298K (-86% year over year), net loss $33.5M, operating cash flow −$31.0M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $298K | $2.1M | −$1.8M | -85% |
| Other income, net | $3.9M | $3.0M | $938K | +32% |
| Net loss | $33.5M | $20.2M | $13.3M | +66% |
| Costs & expenses | $37.7M | $25.2M | $12.5M | +50% |
| Operating costs | $37.7M | $25.2M | $12.5M | +50% |
| Research & development | $30.2M | $18.5M | $11.7M | +63% |
| General & admin | $7.5M | $6.7M | $795K | +12% |
| Operating cash sources | $35.7M | $18.8M | $16.9M | +90% |
| Depreciation | $100K | $0 | $100K | — |
| Share-based compensation | $4.6M | $2.8M | $1.9M | +66% |
| Cash used in operations | $31.0M | $16.0M | $14.9M | +93% |
| Net loss absorbed | $33.5M | $20.2M | $13.3M | +66% |
| Working capital & other | $2.2M | −$1.3M | $3.5M | — |
Questions
How much did BioAge Labs's revenue grow year over year in Q3 2026?
BioAge Labs's revenue fell $1.8M (-85%) from $2.1M in Q3 2025 to $298K in Q3 2026.